A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin's Lymphoma
Clinical trial NCT03343652 · COMPLETED
Trial details
- NCT number
- NCT03343652
- Sponsor
- St. Petersburg State Pavlov Medical University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-27
- Primary completion
- 2019-03-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.